NERI and ProMedica team up to offer Ph I-IV research solutions
US CROs NERI and the ProMedica Clinical Research Center have teamed up to offer comprehensive Phase I-IV trial services to the drug industry.
Archives for May 27, 2009
UK trade office may check GSK and Pfizer HIV joint-venture
GSK and Pfizer’s HIV joint venture (JV) may be subject to an investigation by UK competition watchdog the Office of Fair Trading (OFT), according to various media reports.
TMD adds mutation assays to bolster cancer services
Targeted Molecular Diagnostics (TMD), which was acquired by Quintiles in November 2008, has launched two mutation assays to help clients develop more effective, personalised cancer treatments.
Sanofi receives H1N1 strain and gears up for production
Sanofi Pasteur, the vaccines unit of French drug major Sanofi Aventis, has received a reference strain of the H1N1 swine flu virus from the US CDC and expects to complete work on an industrial “seed stock” in the next two weeks.
BKK sets up in Japan to combat recruitment lag
US Patient recruitment specialist BBK Worldwide has set up a unit in Osaka, Japan to improve enrolment rates for studies in the country and help local pharma and biotech firms cut costs.
Pharma label checker adds new languages
Schlafender Hase has launched a new version of its text verification tool (TVT) that supports all major languages, allowing pharma packagers in all regions to check labels prior to shipping.